5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)autoimmune pulmonary alveolar proteinosisActive, not recruitingPhase 32026-08-26NCT04544293
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMOHemic and Lymphatic Diseases, anemia, hematologic disorderRecruitingNot applicable2026-08-14NCT06560164
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver diseaseActive, not recruitingPhase 32026-07-02NCT04849728
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderRecruitingNot stated2026-03-18NCT07234838
The DRAGON 2 TrialColorectal Cancer Liver Metastases (CRLM); Small Future Liver Remnant (FLR)RecruitingNot applicable2024-11-01NCT05428735